BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32115229)

  • 21. Obstetric outcomes after conservative management of ovarian borderline tumors in women of reproductive age: A single center experience.
    Sobiczewski P; Piatek S; Michalski W; Kupryjańczyk J; Maciejewski T; Ołtarzewski M; Bidzinski M
    Eur J Obstet Gynecol Reprod Biol; 2022 Feb; 269():126-131. PubMed ID: 34998079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fertility and prognosis of borderline ovarian tumor after conservative management: Results of the multicentric OPTIBOT study by the GINECO & TMRG group.
    Chevrot A; Pouget N; Bats AS; Huchon C; Guyon F; Chopin N; Rousset-Jablonski C; Beurrier F; Lambaudie E; Provansal M; Sabatier R; Heinemann M; Ngo C; Bonsang-Kitzis H; Lecuru F; Bailly E; Ferron G; Cornou C; Lardin E; Leblanc E; Philip CA; Ray-Coquard I; Hequet D
    Gynecol Oncol; 2020 Apr; 157(1):29-35. PubMed ID: 32241341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Short Text].
    Bourdel N; Huchon C; Cendos AW; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chéreau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):223-235. PubMed ID: 32004780
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncofertility in patients with stage I epithelial ovarian cancer: fertility-sparing surgery in young women of reproductive age.
    Jiang X; Yang J; Yu M; Xie W; Cao D; Wu M; Pan L; Huang H; You Y; Shen K
    World J Surg Oncol; 2017 Aug; 15(1):154. PubMed ID: 28806962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature.
    Bercow A; Nitecki R; Brady PC; Rauh-Hain JA
    J Minim Invasive Gynecol; 2021 Mar; 28(3):527-536.e1. PubMed ID: 32861046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological and reproductive outcomes after fertility-sparing surgery in patients with seromucinous borderline ovarian tumor: Results of a large retrospective study.
    Wang D; Jia S; Jia C; Cao D; Yang J; Yang J; Xiang Y
    Gynecol Oncol; 2022 Jun; 165(3):446-452. PubMed ID: 35469684
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes after fertility-sparing surgery of early-stage ovarian cancer: A nationwide population-based study.
    Lee CY; Chiang CJ; Tai YJ; Hsu HC; Chen YL; Chiang YC; Wu CY; Lee WC; Hwa HL; Cheng WF
    Cancer Med; 2024 Apr; 13(7):e7132. PubMed ID: 38606892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Fertility].
    Raad J; Rolland L; Grynberg M; Courbiere B; Mathieu d'Argent E
    Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):330-336. PubMed ID: 32004782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline ovarian tumor in pregnancy: can surgery wait? A case series.
    Vidal Urbinati AM; Iacobone AD; Di Pace RC; Pino I; Pittelli MR; Guerrieri ME; Preti EP; Franchi D
    Arch Gynecol Obstet; 2021 Dec; 304(6):1561-1568. PubMed ID: 33950305
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fertility-sparing treatment for serous borderline ovarian tumors with extra-ovarian invasive implants: Analysis from the MITO14 study database.
    Falcone F; Malzoni M; Carnelli M; Cormio G; De Iaco P; Di Donato V; Ferrandina G; Raspagliesi F; Sorio R; Losito NS; Greggi S
    Gynecol Oncol; 2022 May; 165(2):302-308. PubMed ID: 35232587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of patients with an isolated ovarian recurrence after conservative treatment of epithelial ovarian cancer: review of the results of an international multicenter study comprising 545 patients.
    Bentivegna E; Fruscio R; Roussin S; Ceppi L; Satoh T; Kajiyama H; Uzan C; Colombo N; Gouy S; Morice P
    Fertil Steril; 2015 Nov; 104(5):1319-24. PubMed ID: 26149354
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fertility-sparing surgery and survival among reproductive-age women with epithelial ovarian cancer in 2 cancer registries.
    Crafton SM; Cohn DE; Llamocca EN; Louden E; Rhoades J; Felix AS
    Cancer; 2020 Mar; 126(6):1217-1224. PubMed ID: 31774553
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term safety of fertility sparing surgery in early stage ovarian cancer: comparison to standard radical surgical procedures.
    Ditto A; Martinelli F; Bogani G; Lorusso D; Carcangiu M; Chiappa V; Reato C; Donfrancesco C; De Carrillo KJ; Raspagliesi F
    Gynecol Oncol; 2015 Jul; 138(1):78-82. PubMed ID: 25969349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Borderline Ovarian Tumors: Fifteen Years' Experience at a Scottish Tertiary Cancer Center.
    May J; Skorupskaite K; Congiu M; Ghaoui N; Walker GA; Fegan S; Martin CW; O'Donnell RL
    Int J Gynecol Cancer; 2018 Nov; 28(9):1683-1691. PubMed ID: 30365457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Staging procedures fail to benefit women with borderline ovarian tumours who want to preserve fertility: a retrospective analysis of 448 cases.
    Li N; Gou J; Li L; Ming X; Hu TW; Li Z
    BMC Cancer; 2020 Aug; 20(1):769. PubMed ID: 32807135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oncofertility outcomes after fertility-sparing treatment of bilateral serous borderline ovarian tumors: results of a large retrospective study.
    Jia SZ; Xiang Y; Yang JJ; Shi JH; Jia CW; Leng JH
    Hum Reprod; 2020 Feb; 35(2):328-339. PubMed ID: 32048711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
    Nasioudis D; Heyward QD; Ko EM; Haggerty AF; Cory L; Giuntoli Ii RL; Kim SH; Latif NA
    Int J Gynecol Cancer; 2022 Feb; 32(2):165-171. PubMed ID: 34952848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reproductive and oncological outcomes of fertility-sparing surgery in patients with stage I epithelial ovarian cancer: A systematic review and meta-analysis.
    Zhang YF; Fan Y; Mu Y; Zhang P; Wang MY; Li JK
    Medicine (Baltimore); 2022 Aug; 101(31):e29929. PubMed ID: 35945736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.